New

Global ETF Survey 2026 Available: How 620 Professionals Select ETFs. Access the Report →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

Trackinsight Global ETF Survey 2026
›ETF Issuers›Simplify›SURI
SURI

Simplify Propel Opportunities ETF

The SURI Exchange Traded Fund (ETF) is provided by Simplify. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$17.24
+$0.24 (+1.44%) yesterday
6:35 PM 10/29/26 Open
1D price range
$17.00$17.24
52W price range
$14.90$21.31
YTD Perf.
+16.44%
YTD Flows
Annualized volatility
Fund AuM
€68M
Share class AuM
€68M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US82889N6242
TER
2.82%
Inception date
2/7/2023
Issuer
Dividend policy
Compare similar ETFs
ETF Name1w perf.
+4.49%
API
PerformanceDec 31, 2025 - Oct 29, 2026
-10%0%10%20%30%JANMARMAYJULSEP
Flows
Join for free to unlock
Data as of 09/30/26
Healthcare
49.05%
Energy
44.06%
Telecommunications
1.08%
Unavailable
5.80%
Latest SURI news

No content available for this fund

FAQ about SURI

SURI is an actively managed ETF. This ETF provides exposure to Mixed Ratings Aggregate Equities and Bonds.
SURI carries a total expense ratio (TER) of 2.82%.
SURI was introduced to the market on February 7, 2023.
Simplify Propel Opportunities ETF, SURI, is provided by Simplify. Learn more about Simplify here.
SURI oversees €68M in assets as of October 29, 2026.
SURI follows a distributing dividend policy, meaning it pays out income to investors. As of October 29, 2026, its 12-month trailing yield was 15.68%.
As of September 30, 2026, SURI has significant geographic allocations in USA, Canada and United Kingdom.
As of September 30, 2026, SURI focuses largely on Healthcare, Energy and Telecommunications.
As of September 30, 2026, SURI holds 28 positions in its portfolio, with 91.74% of assets concentrated in its top 15 holdings.
As of September 30, 2026, SURI top three holdings include Plains GP Holdings LP, Achieve Life Sciences, Inc. and US0044681874.
The base currency of SURI is USD.
Data as of 09/30/26
Plains GP Holdings LP
44.06%
Achieve Life Sciences, Inc.
12.96%
US0044681874
6.06%
Delcath Systems, Inc.
4.70%
Corcept Therapeutics, Inc.
3.61%
Milestone Pharmaceuticals, Inc.
3.45%
Collegium Pharmaceutical, Inc.
2.75%
Phathom Pharmaceuticals, Inc.
2.29%
Abeona Therapeutics, Inc.
1.95%
Compass Pathways Plc
1.94%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring
Trackinsight Global ETF Survey 2026: ETFs' Next Act: From Access to Selection. Access the report

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight